Recro Pharma Inc (REPH) Insider Trading
- $15,432,705.22
- $23,515,395.34
- July 15, 2022
- Healthcare Master Fun Broadfin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 15, 2022 | Chief Executive Officer | 1,150 | $0.81 | Buy | $931.50 | |
March 18, 2022 | Director | 1,000 | $2.15 | Buy | $2,150.00 | |
March 15, 2022 | CEO | 512 | $1.96 | Buy | $1,003.52 | |
Feb. 15, 2022 | CEO | 571 | $1.77 | Buy | $1,010.67 | |
Jan. 18, 2022 | CEO | 602 | $1.68 | Buy | $1,011.36 | |
Dec. 21, 2021 | Major Shareholder | 99,398 | $1.55 | Sell | $154,066.90 | |
Dec. 15, 2021 | CEO | 617 | $1.61 | Buy | $993.37 | |
Dec. 15, 2021 | Major Shareholder | 20,000 | $1.63 | Sell | $32,600.00 | |
Dec. 13, 2021 | Major Shareholder | 20,000 | $1.63 | Sell | $32,600.00 | |
Nov. 17, 2021 | Director | 1,000 | $1.69 | Buy | $1,690.00 | |
Nov. 12, 2021 | CFO | 1,212 | $1.65 | Buy | $1,999.80 | |
Nov. 12, 2021 | CEO | 1,725 | $1.68 | Buy | $2,898.00 | |
Dec. 22, 2020 | Major Shareholder | 18,830 | $3.17 | Sell | $59,691.10 | |
Dec. 18, 2020 | Major Shareholder | 6,208 | $3.03 | Sell | $18,810.24 | |
April 17, 2020 | CEO | 80,000 | $8.22 | Sell | $657,600.00 | |
May 17, 2019 | Director | 40,000 | $9.00 | Buy | $360,000.00 | |
May 13, 2019 | CEO | 144,806 | $8.89 | Sell | $1,287,325.34 | |
May 24, 2018 | Major Shareholder | 188,000 | $5.81 | Sell | $1,092,280.00 | |
March 13, 2018 | Major Shareholder | 200,000 | $10.07 | Sell | $2,014,000.00 | |
Jan. 3, 2018 | Major Shareholder | 12,964 | $8.88 | Sell | $115,120.32 | |
Dec. 29, 2017 | Major Shareholder | 18,231 | $9.27 | Sell | $169,001.37 | |
Dec. 28, 2017 | Major Shareholder | 1,980 | $9.44 | Sell | $18,691.20 | |
Dec. 27, 2017 | Major Shareholder | 13,189 | $9.56 | Sell | $126,086.84 | |
Dec. 21, 2017 | Major Shareholder | 76,000 | $9.87 | Sell | $750,120.00 | |
Dec. 13, 2017 | Major Shareholder | 93,237 | $9.86 | Sell | $919,316.82 | |
Dec. 5, 2017 | Major Shareholder | 100,000 | $10.00 | Sell | $1,000,000.00 | |
Nov. 30, 2017 | Major Shareholder | 222,616 | $9.58 | Sell | $2,132,661.28 | |
Nov. 28, 2017 | Major Shareholder | 47,549 | $9.64 | Sell | $458,372.36 | |
Nov. 24, 2017 | Major Shareholder | 172,208 | $9.45 | Sell | $1,627,365.60 | |
Nov. 21, 2017 | Major Shareholder | 102,440 | $9.50 | Sell | $973,180.00 | |
June 14, 2017 | Insider | 110,447 | $6.39 | Sell | $705,756.33 | |
June 13, 2017 | Major Shareholder | 32,447 | $6.59 | Sell | $213,825.73 | |
June 12, 2017 | Major Shareholder | 10,000 | $6.74 | Sell | $67,400.00 | |
June 8, 2017 | Insider | 62,868 | $7.06 | Sell | $443,848.08 | |
May 12, 2017 | Major Shareholder | 510,000 | $7.40 | Sell | $3,774,000.00 | |
May 11, 2017 | Major Shareholder | 244,629 | $7.65 | Sell | $1,871,411.85 | |
May 4, 2017 | Major Shareholder | 217,308 | $7.70 | Sell | $1,673,271.60 | |
March 16, 2017 | Major Shareholder | 44,977 | $8.00 | Sell | $359,816.00 | |
Feb. 17, 2017 | Major Shareholder | 9,983 | $7.59 | Sell | $75,770.97 | |
Feb. 16, 2017 | Major Shareholder | 4,030 | $7.89 | Sell | $31,796.70 | |
Dec. 16, 2016 | Director | 800 | $6.71 | Buy | $5,368.00 | |
Dec. 15, 2016 | Director | 1,500 | $6.55 | Buy | $9,825.00 | |
Dec. 13, 2016 | Major Shareholder | 650,000 | $6.00 | Buy | $3,900,000.00 | |
Aug. 16, 2016 | Major Shareholder | 390,000 | $7.50 | Buy | $2,925,000.00 | |
May 31, 2016 | Insider | 1,250 | $8.22 | Buy | $10,275.00 | |
May 23, 2016 | Major Shareholder | 2,503 | $6.30 | Sell | $15,768.90 | |
May 23, 2016 | VP | 2,000 | $6.30 | Buy | $12,600.00 | |
May 20, 2016 | Director | 58,331 | $7.91 | Sell | $461,398.21 | |
May 20, 2016 | Major Shareholder | 6,260 | $6.46 | Sell | $40,439.60 | |
May 19, 2016 | CAO | 1,140 | $6.48 | Buy | $7,387.20 |
Insiders are both buying and selling Recro Pharma Inc stock.
The insider traders at Recro Pharma Inc are: Healthcare Master Fun Broadfin, Scp Vitalife Partners (Israel), J David Enloe Jr, Scp Vitalife Partners Ii Lp, James E Flynn, Geraldine Henwood, Awm Investment Company, Inc., Stonepine Capital Management,, James Charles Miller, Charles Garner, Donna Nichols, Winston J Churchill, Arnaud Ajdler, ENLOE J DAVID JR, Karen Flynn, Randall Mack, Ryan David Lake, Stewart Mccallum, and Alfred Altomari
The most active insider trader at Recro Pharma Inc is Healthcare Master Fun Broadfin with 13 trades.
Healthcare Master Fun Broadfin has sold the most Recro Pharma Inc stock with a total value of $12,059,576.06.
Healthcare Master Fun Broadfin has bought the most Recro Pharma Inc stock with a total value of $18,828,359.80.
The most recent insider trade for Recro Pharma Inc was on July 15, 2022.
The single biggest insider buy for Recro Pharma Inc was from Healthcare Master Fun Broadfin with a total value of $7,500,014.80 on July 7, 2015.
The single biggest insider sell for Recro Pharma Inc was from Stonepine Capital Management, with a total value of $3,774,000.00 on May 12, 2017.